Showing 8231-8240 of 19301 results for "".
Beyond the Embryonic Stem Cell Debate
https://reachmd.com/programs/clinicians-roundtable/beyond-the-embryonic-stem-cell-debate/4314/Although President Obama has favored funding for embryonic stem cell research, the moral debate continues. But that discussion may overshadow the fact that biotech companies have actually made the most early progress, not in embryonic stem cells, but in adult stem cells. Dr. Robert Harman, chief exeLiving Donors
https://reachmd.com/programs/clinicians-roundtable/living-donors/1675/Has a patient asked you yet, your medical opinion regarding their decision to become a living donor? The number of living liver donors is growing each year. The ability to give the gift of life to another is appealing to many but what are the costs? What are the risks? What are the health requirUnderstanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Patient-Centric Care in Rheumatic Disease: Alternative Approaches to Managing Pain
https://reachmd.com/programs/living-rheum/patient-centric-care-in-rheumatic-disease-alternative-approaches-to-managing-pain/30078/Explore the future of pain management in rheumatic diseases.What Are the Latest Advances in Lupus Care?
https://reachmd.com/programs/conference-coverage/what-are-the-latest-advances-in-lupus-care/10308/Although nonrenal lupus patients face a variety of challenges, there’s fortunately been a lot of advances in care, as outlined by a guru in lupus.Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
https://reachmd.com/programs/neurofrontiers/Data-Equity-in-Action-Largest-Real-World-MS-Analysis-Confirms-Fumarate-Efficacy-Across-Racial-Groups/36351/Retina Rumble: Debating Modern Treatment Options
https://reachmd.com/programs/cme/retina-rumble-debating-modern-treatment-options/54609/Join this lively case-based debate moderated by Dr. Goldberg on selecting second-generation therapies for retinal diseases with Drs. Modi and Weng.mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
https://reachmd.com/programs/project-oncology/mcrpc-care-reducing-progression-risk-by-combining-enzalutamide-and-talazoparib/17801/Dive into the findings from the TALAPRO-2 trial, which examined a combination regimen for metastatic castration-resistant prostate cancer.Light-Based Therapies for Alopecia: What’s Established and What’s Emerging
https://reachmd.com/programs/dermconsult/light-based-therapies-alopecia-established-emerging/49024/Modern Approaches to Long-Term Metastatic Breast Cancer Care
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/long-term-metastatic-breast-cancer-care/48712/Advances in systemic therapies have transformed metastatic breast cancer into a long-term, treatable condition for many patients. Learn more as Dr. Charles Turck sits down with Dr. Adam Brufsky to discuss how we can support these patients by prioritizing quality of life, addressing long-term toxicit